News
- Author:
- Alicia Ault
Publish date: June 19, 2024
Researchers review posts by physicians on X, looking for key words that might indicate that the posts were intended as endorsements of a product.
News
- Author:
- Alicia Ault
Publish date: May 30, 2024
The once-daily extended-release oral suspension, with nighttime dosing, can be used alone or as an adjunctive therapy to FDA-approved stimulant med...
News
- Author:
- Alicia Ault
Publish date: May 29, 2024
Teens whose classmates have mental illnesses are 3% more likely to later receive a psychiatric diagnosis, study finds.
News
- Author:
- Alicia Ault
Publish date: April 12, 2024
ADHD is the second-most common psychiatric disorder in adults but mental health professionals report a lack of familiarity with the disorder in adu...
News
- Author:
- Alicia Ault
Publish date: April 11, 2024
A randomized, controlled, blinded study finds little difference between the two forms of the drug in promoting hair growth in men.
News
- Author:
- Alicia Ault
Publish date: April 3, 2024
Industry payments appeared to have been little changed by public reporting in the Open Payments database.
News
- Author:
- Alicia Ault
Publish date: March 28, 2024
The Florida legislation will allow physician assistants and advanced practice nurses who operate under the supervision of a dermatologist to conduc...
News
- Author:
- Alicia Ault
Publish date: March 19, 2024
The FDA noted that a key principle in developing guidance for early Alzheimer’s disease therapies is that treatment “must begin before there are ov...
News
- Author:
- Alicia Ault
Publish date: March 12, 2024
Adderall has been in short supply for a year and half due to several causes, which have not yet been resolved.
News
- Author:
- Alicia Ault
Publish date: March 12, 2024
Questions about the validity of some Alzheimer’s research has potentially slowed progress in treatment of the disease.
News
- Author:
- Alicia Ault
Publish date: February 23, 2024
The use of methamphetamine by people who also use fentanyl reached a record high in 2023.
News
- Author:
- Alicia Ault
Publish date: February 9, 2024
"The wider indication granted by the FDA may lead to friction between payers on the one hand and patients and physicians on the other," the authors...
News
- Author:
- Alicia Ault
Publish date: February 5, 2024
Immune checkpoint inhibitors offer promise but organ rejection still a major concern with their use.
News
- Author:
- Alicia Ault
Publish date: January 29, 2024
The FDA said in its report that cannabis is a low-risk threat to public health.
News
- Author:
- Alicia Ault
Publish date: January 9, 2024
Bromazolam is one of at least a dozen designer benzodiazepines created in the lab but not approved for any therapeutic use.
